Bioleaders Corporation announced a private placement of 5,000,000 common shares at an issue price of KRW 2,000 per share for the gross proceeds of KRW 10,000,000,000 on March 12, 2024. The transaction will include participation from new investor Moadata Co., Ltd. The transaction has been approved by the shareholders of the company and is expected to close on April 15, 2024. The shares are restricted to a hold period of 1 year.